Markers of Proliferative Diabetic Retinopathy
Open Access
- 6 October 2022
- journal article
- review article
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 19 (3) , 557-564
Abstract
The incidence of diabetes mellitus (DM) is steadily growing and today the World Health Organization (WHO) describes this situation as an epidemic. Diabetic retinopathy (DR) is one of the most common complications of DM, as well as one of the main causes of acquired irreversible vision loss. Nowadays the pathogenesis of proliferative DR remains completely unexplored, but many authors think about the important role of biologically significant mediators of this process cytokines and growth factors. Cytokines and growth factors are protein mediators that regulate various functions, both locally and systemically. They carry out the cells’ life cycle, the processes of proliferation, participate in the regulation of the protective inflammatory response of the body, control angiogenesis and other mechanisms. It is proved that the main links in the pathogenesis of DR are oxidative stress, thickening of the endothelial basement membrane in capillaries, loss of pericytes, end products of glycation and inflammation. Chorioretinal hypoxia and ischemia play a major role in the formation of newly formed vessels. Newly formed vessels are defective (with a thin wall devoid of pericytes), often lead to hemorrhages, hypoxia, which in turn closes the pathological circle and causes the production of cytokines and vasoproliferative factors. Frequent complications of DR are intraocular hemorrhages, retinal fibrosis and pathological changes in the posterior hyaloid membrane, traction retinal detachment, etc. This review examines some types of cytokines and growth factors and their role in the light in the pathogenesis of proliferative DR. Modern technologies make it possible to conduct effective studies of intraocular fluids to study the content of biologically active substances both in the moisture of the anterior chamber of the eye and in the vitreous body. To narrow the scope of the review on the subject attention is focused on the works that examined various markers locally in the intraocular fluids in patients with DM. It is worth noting that there are few such studies and their results often differ significantly from each other. This fact is a subject for discussion and encourages further study of this topic.Keywords
This publication has 46 references indexed in Scilit:
- Vitreous TIMP-1 levels associate with neovascularization and TGF-β2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathyJournal of Cell Communication and Signaling, 2012
- Usefulness of the Vitreous Fluid Analysis in the Translational Research of Diabetic RetinopathyMediators of Inflammation, 2012
- Tying the knot: The cystine signature and molecular‐recognition processes of the vascular endothelial growth factor family of angiogenic cytokinesThe FEBS Journal, 2011
- Inflammation in diabetic retinopathyProgress in Retinal and Eye Research, 2011
- Inflammatory cytokines in vascular dysfunction and vascular diseaseBiochemical Pharmacology, 2009
- Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and PhotoreceptorsPLOS ONE, 2008
- Vitreous Levels of Interleukin-8 in Patients With Proliferative Diabetic RetinopathyAmerican Journal of Ophthalmology, 2007
- Interleukin‐8, monocyte chemoattractant protein‐1 and IL‐10 in the vitreous fluid of patients with proliferative diabetic retinopathyDiabetic Medicine, 2005
- Vascular Endothelial Growth Factor and AngiogenesisPharmacological Reviews, 2004
- Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retinaBritish Journal of Ophthalmology, 2004